We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

LabMedica

Download Mobile App
Recent News Expo Clinical Chem. Molecular Diagnostics Hematology Immunology Microbiology Pathology Technology Industry Focus

When Exercise Is Unhealthy: Study Sheds New Light on Sudden Cardiac Death

By LabMedica International staff writers
Posted on 06 Dec 2015
Print article
Researchers have discovered new aspects, involving a mutated protein, of a not-well-understood mechanism that underlies how sudden heart failure can occur during endurance exercise in patients with arrhythmogenic ventricular cardiomyopathy (AVC), which currently has no standardized guidelines for exercise management. The findings may inform development of early diagnostics, drug treatments, and personalized exercise programs.

AVC is the most common heart condition that causes sudden cardiac death during intense exercise. Using various analyses of cardiac function and morphology, a team led by Jeffrey A. Towbin, MD, of the University of Tennessee Health Science Center (Memphis, TN, USA), in collaboration with researchers from Cincinnati Children’s Hospital Medical Center (Cincinnati, OH, USA) and others has found that in mice with a known mutated version of desmoplakin, a protein that helps maintain the structure of the heart wall, exercise made the heart walls come apart sooner, leading to earlier development of AVC.

Heart wall cells are stacked in interlocking layers attached to each other by desmosomes that dot the surface of the cells. Exercise can overstretch the heart wall, but these intercellular links keep the cells from disconnecting from each other and prevent the heart wall from coming apart. Desmosomes are made up of several proteins, including desmoplakin. Defects can weaken the cell-cell links, as in AVC, such that the cells do not withstand the extra stretch from exercise and so detach from each other. Scar tissue fills the gaps between the disconnected cells, further reducing the wall’s ability to withstand increased workload as in exercise.

Several studies observed that mice with a mutated form of desmoplakin developed the same heart problems seen in patients with AVC. In this new study, in addition to finding that endurance exercise led to earlier onset of AVC symptoms in the mice with the mutated desmoplakin, the researchers also discovered that the desmosomes started coming apart before changes in heart function were detected and that exercise perturbed AKT1 and GSK3-β signaling in the Wnt-β-catenin pathway, which promotes growth of new cells and prevents deposition of fat, offering an explanation for the accelerated development of AVC.

The study suggests that changes in the cell-cell links can be detected before alterations in heart function occur. This could help identify individuals with the mutation before they develop AVC symptoms, said Dr. Towbin, opening the possibility of better strategies to prevent exercise-induced complications and of developing drugs targeting the Wnt-β-catenin pathway to potentially help AVC patients.

The study, by Martherus R et al., was published online ahead of print November 6, 2015, in the American Journal of Physiology — Heart & Circulatory Physiology.

Related Links:

University of Tennessee Health Science Center
Cincinnati Children’s Hospital Medical Center


Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
Magnetic Bead Separation Modules
MAG and HEATMAG
Complement 3 (C3) Test
GPP-100 C3 Kit
New
Gold Member
Magnetic Bead Separation Modules
MAG and HEATMAG

Print article

Channels

Clinical Chemistry

view channel
Image: The 3D printed miniature ionizer is a key component of a mass spectrometer (Photo courtesy of MIT)

3D Printed Point-Of-Care Mass Spectrometer Outperforms State-Of-The-Art Models

Mass spectrometry is a precise technique for identifying the chemical components of a sample and has significant potential for monitoring chronic illness health states, such as measuring hormone levels... Read more

Hematology

view channel
Image: The CAPILLARYS 3 DBS devices have received U.S. FDA 510(k) clearance (Photo courtesy of Sebia)

Next Generation Instrument Screens for Hemoglobin Disorders in Newborns

Hemoglobinopathies, the most widespread inherited conditions globally, affect about 7% of the population as carriers, with 2.7% of newborns being born with these conditions. The spectrum of clinical manifestations... Read more

Immunology

view channel
Image: Exosomes can be a promising biomarker for cellular rejection after organ transplant (Photo courtesy of Nicolas Primola/Shutterstock)

Diagnostic Blood Test for Cellular Rejection after Organ Transplant Could Replace Surgical Biopsies

Transplanted organs constantly face the risk of being rejected by the recipient's immune system which differentiates self from non-self using T cells and B cells. T cells are commonly associated with acute... Read more

Microbiology

view channel
Image: The ePlex system has been rebranded as the cobas eplex system (Photo courtesy of Roche)

Enhanced Rapid Syndromic Molecular Diagnostic Solution Detects Broad Range of Infectious Diseases

GenMark Diagnostics (Carlsbad, CA, USA), a member of the Roche Group (Basel, Switzerland), has rebranded its ePlex® system as the cobas eplex system. This rebranding under the globally renowned cobas name... Read more

Pathology

view channel
Image: The revolutionary autonomous blood draw technology is witnessing growing demands (Photo courtesy of Vitestro)

Robotic Blood Drawing Device to Revolutionize Sample Collection for Diagnostic Testing

Blood drawing is performed billions of times each year worldwide, playing a critical role in diagnostic procedures. Despite its importance, clinical laboratories are dealing with significant staff shortages,... Read more